Bridgewater Associates’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-92,377
| Closed | -$22.7M | – | 951 |
|
2022
Q3 | $22.7M | Buy |
92,377
+2,152
| +2% | +$529K | 0.11% | 144 |
|
2022
Q2 | $22.3M | Buy |
90,225
+23,353
| +35% | +$5.78M | 0.09% | 186 |
|
2022
Q1 | $22.2M | Buy |
66,872
+17,874
| +36% | +$5.92M | 0.09% | 163 |
|
2021
Q4 | $17.6M | Buy |
48,998
+2,451
| +5% | +$880K | 0.1% | 135 |
|
2021
Q3 | $15.2M | Sell |
46,547
-2,374
| -5% | -$773K | 0.08% | 152 |
|
2021
Q2 | $15.3M | Buy |
48,921
+17,920
| +58% | +$5.59M | 0.1% | 162 |
|
2021
Q1 | $9.88M | Buy |
31,001
+5,084
| +20% | +$1.62M | 0.09% | 163 |
|
2020
Q4 | $8.4M | Buy |
25,917
+15,226
| +142% | +$4.94M | 0.07% | 145 |
|
2020
Q3 | $2.96M | Buy |
+10,691
| New | +$2.96M | 0.04% | 206 |
|